Joseph A. Sparano, MD, on Multimodal AI Models for Predicting Breast Cancer Recurrence

February 04, 2026 By The ASCO Post Staff

Joseph A. Sparano, MD, of the Icahn School of Medicine at Mount Sinai, discusses the performance of experimental multimodal artificial intelligence (AI) models integrating clinical, molecular, and histopathologic features to provide prognostic information for early and late recurrence using primary tumor samples and clinical data from participants in the TAILORx trial (Abstract GS1-08). 

Related Content